Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 13/20 | 1.00 |
| ▸ | CYP11B2 | P19099 | 12/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.70 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.70 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.67 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.67 |
| ▸ | QPCT | Q16769 | 1/20 | 0.67 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.67 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.67 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30946847 | 0.98 | CYP11B1 (0.96) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL6488945 | 0.95 | CYP11B1 (0.90) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL1024261 | 0.90 | CYP11B1 (0.84) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| Hydrochloric Acid SCHEMBL1775141 | 0.88 | CYP11B1 (0.81) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL7284368 | 0.85 | CYP11B1 (0.73) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL6057476 | 0.84 | CYP11B1 (0.75) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL2529997 | 0.84 | CYP11B1 (0.86) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| Ethoxycarbonyl Group SCHEMBL27679354 | 0.83 | CYP11B1 (0.68) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL570342 | 0.82 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 | |
| SCHEMBL2729830 | 0.82 | CYP11B1 (1.00) | CYP11B1CYP11B2CYP19A1CYP2A6CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861256-B | Preparation method and application of 16, 17-dihydroxysteroid compound | 天津药业研究院股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| CN-117503807-A | Preparation process of cordyceps militaris powder | 江西仙客来生物科技有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-116478344-A | Water-based single-component epoxy emulsion and preparation method thereof | 万华化学集团股份有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-112581856-B | Temperature indicating label | 苏州和萃新材料有限公司 | 2022-07-19 | — | — | CN | claimed |
| CN-113861256-A | Preparation method and application of 16, 17-dihydroxysteroid compound | 天津药业研究院股份有限公司 | 2021-12-31 | — | — | CN | claimed |
| CN-113789086-A | High-temperature color-changing ink and label | 江苏集萃智能液晶科技有限公司 | 2021-12-14 | — | — | CN | claimed |
| CN-109065832-B | Method for growing protective layer on surface of metal negative electrode of secondary lithium battery | 武汉船用电力推进装置研究所（中国船舶重工集团公司第七一二研究所） | 2021-07-09 | — | — | CN | claimed |
| CN-112581856-A | Temperature indicating label | 苏州和萃新材料有限公司 | 2021-03-30 | — | — | CN | claimed |
| CN-110343205-A | Side group functionalized polyisobutylene base thermoplastic elastomer and preparation method thereof | 北京化工大学 | 2019-10-18 | — | — | CN | claimed |
| CN-109336756-A | A kind of hydrogenation-dehalogenation method of halogenated aromatic | 河南大学 | 2019-02-15 | — | — | CN | claimed |
| CN-109065832-A | A method of in serondary lithium battery metal negative electrode surface growth protecting layer | 武汉船用电力推进装置研究所（中国船舶重工集团公司第七二研究所） | 2018-12-21 | — | — | CN | claimed |
| CN-105176528-B | A kind of preparation method of nitrogen-doped carbon based quantum dot | 中物院成都科学技术发展中心 | 2018-02-23 | — | — | CN | claimed |
| EP-2611797-B1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI SCIENCE CO LTD (KR) | 2016-12-28 | — | — | EP | claimed |
| CN-105176528-A | Preparation method of nitrogen doped carbon based quantum dot | UNIV CHENGDU | 2015-12-23 | — | — | CN | claimed |
| US-8835458-B2 | Quinoline or quinazoline derivatives with apoptosis inducing activity on cells | HANMI SCIENCE CO., LTD (KR) | 2014-09-16 | — | — | US | claimed |
| EP-2611797-A2 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | Hanmi Science Co., Ltd. (KR) | 2013-07-10 | — | — | EP | claimed |
| US-20130165386-A1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI SCIENCE CO., LTD (KR) | 2013-06-27 | — | — | US | claimed |
| WO-2012030160-A2 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | HANMI HOLDINGS CO., LTD. (KR) | 2012-03-08 | — | — | WO | claimed |
| US-20040110778-A1 | Heterocyclic compounds as ligands of the GABAA receptor | YOHANNES DANIEL (US) | 2004-06-10 | — | — | US | claimed |
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | PFIZER INC | 2003-06-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | GABRB1, GABRP, GABRA1 | CYP11B1 328/4885CYP11B2 336/4885CYP19A1 543/4885 |
| US-20040110778-A1 | Heterocyclic compounds as ligands of the GABAA receptor | GABRB1, GABRP, GABRA1 | CYP11B1 328/4885CYP11B2 336/4885CYP19A1 543/4885 |
| US-20130165386-A1 | QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS | CASP7, API5, BAX | CYP11B1 3978/4885CYP11B2 3908/4885CYP19A1 3692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.